Harmonization of acquisition and analysis protocols is an important step in the validation of
BOLD MRI as a renal biomarker. This harmonization initiative provides technical …

Accurate diagnosis, monitoring and treatment decisions in patients with chronic liver disease
currently rely on biopsy as the diagnostic gold standard, and this has constrained early …

Background and aims Hepatic steatosis is the most common histopathological finding on
liver biopsy, with the most prevalent etiology being NAFLD. The pathogenesis of hepatic …

Abstract Background and Objective To model hepatic steatosis in adult humans with non-
alcoholic fatty liver disease based on stereology and spatial distribution of fat droplets from …

Purpose To design, construct, and evaluate quantitative MR phantoms that mimic MRI
signals from the liver with simultaneous control of three parameters: proton‐density fat …

Purpose To evaluate the precision profile (repeatability and reproducibility) of quantitative
STEAM‐MRS and to determine the relationships between multiple MR biomarkers of chronic …

Background Different regional depots of fat have distinct metabolic properties and may
relate differently to adverse cardiac remodeling. We sought to quantify regional depots of …

Chronic liver disease (CLD) has rapidly increased in prevalence over the past two decades,
resulting in significant morbidity and mortality worldwide. Historically, the clinical gold …

Purpose To show that both susceptibility-weighted imaging (SWI) and T2*-mapping are
dependent on liver steatosis, which should be taken into account when using these …

Objectives MRI quantification of liver iron concentration (LIC) using R2 or R2* relaxometry
requires offline post-processing causing reporting delays, administrative overhead, and …